4-Quinolone-resistant Neisseria gonorrhoeae in the United Kingdom

References

1. Oriel J. D. Ciprofloxacin in the treatment of gonorrhoea and non-gonococcal urethritis. J Antimicrob Chemother 1986; 18: Suppl D 129–132
   [Google Scholar]
2. Loo P. S., Ridgway G. L., Oriel J. D. Single dose ciprofloxacin for treating gonococcal infections in men. Genitourin Med 1985; 61:302–305
   [Google Scholar]
3. Tegelberg-Stassen MJ, van der Hoek J. C., Mooi L. Treatment of uncomplicated gonococcal urethritis in men with two dosages of ciprofloxacin. Eur J Clin Microbiol 1986; 5:244–246
   [Google Scholar]
4. Shahmanesh M., Shukla S. R., Phillips I., Westwood A, Thin R. W. Ciprofloxacin for treating urethral gonorrhoea in men. Genitourin Med 1986; 62:86–87
   [Google Scholar]
5. Gransden W. R., Warren C. A., Phillips I., Hodges M, Barlow D. Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin. Lancet 1990; 335:51
   [Google Scholar]
6. Jephcott A., Turner A. Ciprofloxacin resistance in gonococci. Lancet 1990; 335:165
   [Google Scholar]
7. Ison C. A., Easmon C. S. F. Changes in penicillinase-producing Neisseria gonorrhoeae isolated in London. J Med Microbiol 1989; 30:239–244
   [Google Scholar]
8. Knapp J. S., Tam M. R., Nowinski R. C., Holmes K. K., Sanstrom E. G. Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J Infect Dis 1984; 150:44–48
   [Google Scholar]
9. Copley C. G., Egglestone S. I. Auxotyping of Neisseria gonorrhoeae isolated in the United Kingdom. J Med Microbiol 1983; 16:295–302
   [Google Scholar]
10. Warren C. A., Shannon K. P., Phillips I. In-vitro antigonococcal activity of reosoxacin (WIN 35212). Br J Vener Dis 1981; 57:33–35
    [Google Scholar]
11. Phillips I., King A., Shannon K. In-vitro properties of the quinolones. In Andriole V. T. (ed) The quinolones London: Academic Press; 198883–117
    [Google Scholar]
12. Manek N., Andrews J. M., Wise R. In-vitro activity of Ro 23 6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agents. Antimicrob Agents Chemother 1986; 30:330–332
    [Google Scholar]
13. Beskid G., Fallat V., Lipschitz E. R. In-vitro activities of a dual-action antibacterial agent, Ro 23−9424, and comparative agents. Antimicrob Agents Chemother 1989; 33:1072–1077
    [Google Scholar]
14. Hardy D. J., Swanson R. N., Hensey D. M. Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones. Antimicrob Agents Chemother 1987; 31:1768–1774
    [Google Scholar]
15. Woodford N., Bindayana K. M., Easmon C. S. F., Ison C. A. Associations between serotype and susceptibility to antibiotics of Neisseria gonorrhoeae. Genitourin Med 1989; 65:86–91
    [Google Scholar]
16. Young H., Moyes A., Tait I. B., McCartney A. C, Gallacher G. Non-typable quinolone-resistant gonococci. Lancet 1990; 335:604
    [Google Scholar]
17. Joyce M. P., Aying B. B. Vaughan GH et al., In-vitro sensitivity of Neisseria gonorrhoeae to quinolone antibiotics in the Republic of the Philippines. Sixth International Pathogenic Neisseria Conference, Atlanta, GA 1988 Abstract E19
    [Google Scholar]
18. MacAulay M. E. Acrosoxacin resistance in Neisseria gonorrhoeae. Lancet 1982; I:171–172
    [Google Scholar]
19. Hirai K., Aoyama H., Suzue S., Irikura T., Iyobe S., Mitsuhashi S. Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12. Antimicrob Agents Chemother 1986; 30:248–253
    [Google Scholar]
20. Aoyama H., Sato K., Kato T., Hirai K., Mitsuhashi S. Norfloxacin resistance in a clinical isolate of Escherichia coli. Antimicrob Agents Chemother 1987; 31:1640–1641
    [Google Scholar]
21. Hirai K., Aoyama H., Irikura T., Iyobe S., Mitsuhashi S. Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli. Antimicrob Agents Chemother 1986; 29:535–538
    [Google Scholar]
22. Hooper D. C., Wolfson J. S., Souza K. S., Tung C., McHugh G. L., Swartz M. N. Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli. Antimicrob Agents Chemother 1986; 29:639–644
    [Google Scholar]